These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 11590405)
1. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Albert ML; Jegathesan M; Darnell RB Nat Immunol; 2001 Nov; 2(11):1010-7. PubMed ID: 11590405 [TBL] [Abstract][Full Text] [Related]
2. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function. Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769 [TBL] [Abstract][Full Text] [Related]
3. IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens. Lapenta C; Santini SM; Spada M; Donati S; Urbani F; Accapezzato D; Franceschini D; Andreotti M; Barnaba V; Belardelli F Eur J Immunol; 2006 Aug; 36(8):2046-60. PubMed ID: 16856207 [TBL] [Abstract][Full Text] [Related]
4. Aqueous extract of Phyllanthus niruri (Euphorbiaceae) enhances the phenotypic and functional maturation of bone marrow-derived dendritic cells and their antigen-presentation function. Nworu CS; Akah PA; Okoye FB; Esimone CO Immunopharmacol Immunotoxicol; 2010 Sep; 32(3):393-401. PubMed ID: 20095802 [TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells. Brossart P; Zobywalski A; Grünebach F; Behnke L; Stuhler G; Reichardt VL; Kanz L; Brugger W Cancer Res; 2000 Aug; 60(16):4485-92. PubMed ID: 10969796 [TBL] [Abstract][Full Text] [Related]
6. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule. McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604 [TBL] [Abstract][Full Text] [Related]
7. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules. Mauri D; Wyss-Coray T; Gallati H; Pichler WJ J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409 [TBL] [Abstract][Full Text] [Related]
8. Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway. McLellan AD; Sorg RV; Williams LA; Hart DN Eur J Immunol; 1996 Jun; 26(6):1204-10. PubMed ID: 8647193 [TBL] [Abstract][Full Text] [Related]
9. A CD40/CD40L feedback loop drives the breakdown of CD8(+) T-cell tolerance following depletion of suppressive CD4(+) T cells. Muth S; Schütze K; Hain T; Yagita H; Schild H; Probst HC Eur J Immunol; 2014 Apr; 44(4):1099-107. PubMed ID: 24420080 [TBL] [Abstract][Full Text] [Related]
10. ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells. Witsch EJ; Peiser M; Hutloff A; Büchner K; Dorner BG; Jonuleit H; Mages HW; Kroczek RA Eur J Immunol; 2002 Sep; 32(9):2680-6. PubMed ID: 12207353 [TBL] [Abstract][Full Text] [Related]
11. Evidence that induction of tolerance in vivo involves active signaling via a B7 ligand-dependent mechanism: CTLA4-Ig protects V beta 8+ T cells from tolerance induction by the superantigen staphylococcal enterotoxin B. Lane P; Haller C; McConnell F Eur J Immunol; 1996 Apr; 26(4):858-62. PubMed ID: 8625979 [TBL] [Abstract][Full Text] [Related]
12. Critical role of costimulation in the activation of naive antigen-specific TCR transgenic CD8+ T cells in vitro. Chai JG; Vendetti S; Bartok I; Schoendorf D; Takacs K; Elliott J; Lechler R; Dyson J J Immunol; 1999 Aug; 163(3):1298-305. PubMed ID: 10415027 [TBL] [Abstract][Full Text] [Related]
13. Characteristics of antigen-independent and antigen-dependent interaction of dendritic cells with CD4+ T cells. Hauss P; Selz F; Cavazzana-Calvo M; Fischer A Eur J Immunol; 1995 Aug; 25(8):2285-94. PubMed ID: 7545116 [TBL] [Abstract][Full Text] [Related]
14. Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells. Yin W; Gorvel L; Zurawski S; Li D; Ni L; Duluc D; Upchurch K; Kim J; Gu C; Ouedraogo R; Wang Z; Xue Y; Joo H; Gorvel JP; Zurawski G; Oh S EBioMedicine; 2016 Mar; 5():46-58. PubMed ID: 27077111 [TBL] [Abstract][Full Text] [Related]
15. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis. Jenne L; Arrighi JF; Jonuleit H; Saurat JH; Hauser C Cancer Res; 2000 Aug; 60(16):4446-52. PubMed ID: 10969791 [TBL] [Abstract][Full Text] [Related]
16. CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells. Ribas A; Butterfield LH; Amarnani SN; Dissette VB; Kim D; Meng WS; Miranda GA; Wang HJ; McBride WH; Glaspy JA; Economou JS Cancer Res; 2001 Dec; 61(24):8787-93. PubMed ID: 11751400 [TBL] [Abstract][Full Text] [Related]
17. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation. Tao X; Constant S; Jorritsma P; Bottomly K J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393 [TBL] [Abstract][Full Text] [Related]
18. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function. Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975 [TBL] [Abstract][Full Text] [Related]
19. Partial activation of naive CD4 T cells and tolerance induction in response to peptide presented by resting B cells. Croft M; Joseph SB; Miner KT J Immunol; 1997 Oct; 159(7):3257-65. PubMed ID: 9317124 [TBL] [Abstract][Full Text] [Related]
20. Polymorphonuclear neutrophils deliver activation signals and antigenic molecules to dendritic cells: a new link between leukocytes upstream of T lymphocytes. Megiovanni AM; Sanchez F; Robledo-Sarmiento M; Morel C; Gluckman JC; Boudaly S J Leukoc Biol; 2006 May; 79(5):977-88. PubMed ID: 16501052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]